Summary:
- This article discusses the European Medicines Agency's (EMA) efforts to provide improved scientific advice on medicines that can help address public health threats, including antimicrobial resistance.
- The EMA aims to enhance its scientific advice process to better support the development of new and improved medicines that can address emerging public health challenges, such as the growing threat of antimicrobial resistance.
- The article highlights the importance of this initiative in helping to ensure that the healthcare system is better prepared to respond to evolving public health needs and to develop effective solutions to combat critical issues like antimicrobial resistance.